Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122515993 | 12251599 | 3 | F | 201512 | 20160720 | 20160410 | 20160822 | PER | US-JNJFOC-20160308623 | JANSSEN | 21.91 | YR | A | M | Y | 74.84000 | KG | 20160822 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122515993 | 12251599 | 1 | SS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | Y | U | UNKNOWN;UNKNOWN | 0 | 156 | MG | INJECTION | |||||
| 122515993 | 12251599 | 2 | PS | INVEGA SUSTENNA | PALIPERIDONE PALMITATE | 1 | Intramuscular | Y | U | UNKNOWN;UNKNOWN | 22264 | 234 | MG | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122515993 | 12251599 | 1 | Bipolar disorder |
| 122515993 | 12251599 | 2 | Bipolar disorder |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122515993 | 12251599 | Abnormal behaviour | |
| 122515993 | 12251599 | Abulia | |
| 122515993 | 12251599 | Adverse drug reaction | |
| 122515993 | 12251599 | Akathisia | |
| 122515993 | 12251599 | Anhedonia | |
| 122515993 | 12251599 | Anxiety | |
| 122515993 | 12251599 | Apathy | |
| 122515993 | 12251599 | Boredom | |
| 122515993 | 12251599 | Cognitive disorder | |
| 122515993 | 12251599 | Decreased interest | |
| 122515993 | 12251599 | Depression | |
| 122515993 | 12251599 | Discomfort | |
| 122515993 | 12251599 | Emotional poverty | |
| 122515993 | 12251599 | Exercise tolerance decreased | |
| 122515993 | 12251599 | Fatigue | |
| 122515993 | 12251599 | Fear | |
| 122515993 | 12251599 | Feeling abnormal | |
| 122515993 | 12251599 | Head discomfort | |
| 122515993 | 12251599 | Laziness | |
| 122515993 | 12251599 | Mobility decreased | |
| 122515993 | 12251599 | Negative thoughts | |
| 122515993 | 12251599 | Nightmare | |
| 122515993 | 12251599 | Off label use | |
| 122515993 | 12251599 | Product use issue | |
| 122515993 | 12251599 | Restlessness | |
| 122515993 | 12251599 | Self-injurious ideation | |
| 122515993 | 12251599 | Sensory disturbance | |
| 122515993 | 12251599 | Tobacco user | |
| 122515993 | 12251599 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122515993 | 12251599 | 1 | 20151225 | 20151225 | 0 | |
| 122515993 | 12251599 | 2 | 20151222 | 20151225 | 0 |